About Concure Oncology
Concure Oncology is a Healthcare company based in Mercer Island (United States) founded in 2014. Breast microseed radiotherapy for early-stage breast cancer is developed. Concure Oncology has raised $14.04 million across 6 funding rounds from investors including Cascadia Venture Forum. Its focus areas include Life Sciences, Oncology, Medical Devices and Therapies. Its competitors include Koya Medical, Sensus Healthcare and Theragenics; 3 of its 3 listed competitors have raised funding.
Company details
Concure Oncology provides an innovative cancer treatment for women diagnosed with early-stage breast cancer. The company has developed a proprietary technology, Breast Microseed Treatment involves the use of Brancy therapy for the precise placement of radioactive seeds in the breast that slowly release the prescribed dose safely over time. This radiation therapy will help the women with early-stage breast cancer to prevent the recurrence of cancer by treating the surgical site and surrounding tissue after the cancerous tumor is removed.
- Headquarters Mercer Island, United States
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website breastmicroseed.com
- Social LinkedIn X Facebook
- Total Equity Funding$14.04M (USD)
in 6 rounds
- Latest Funding Round$7.46M (USD), Series A
Aug 2020
- Investors
Funding Insights of Concure Oncology
Concure Oncology has successfully raised a total of $14.04M across 6 strategic funding rounds. The most recent funding activity was a Series A round of $7.46 million completed in August 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $14.04M
- Total Rounds 6
- Last Round Series A — $7.46M
- First Round $500,000
(Dec 2015)
- Investors Count 1
All 6 funding rounds of Concure Oncology with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug 2020 | $7.46M | Series A | – | – | – |
| Sep 2019 | $3.04M | Series A | – | – | – |
| Dec 2017 | $825,000 | Seed | – | Cascadia Venture Forum | – |
| May 2017 | $563,817 | Seed | – | – | – |
| Mar 2016 | $1.66M | Seed | – | – | – |
| Dec 2015 | $500,000 | Seed | – | – | – |
1 investors in total: 1 institutional.
Investors in Concure Oncology
Concure Oncology has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Cascadia Venture Forum.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
| cascadiaventureforum.com |
Investor details for Concure Oncology
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Concure Oncology
3 dated milestones of Concure Oncology across 6 years, from founding to its latest funding, stage changes and deals.
- Founded Concure Oncology is founded.
- Funding First funding round of $500K.
- Funding Latest funding round, Series A, of $7.5M.
Competitors of Concure Oncology
Concure Oncology has 3 listed competitors in our database, 3 of them funded. They include Koya Medical, Sensus Healthcare and Theragenics.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| koyamedical.com | 2018 | Oakland, United States | $37.02M | 122 | Provider of smart wearable compression technology for lymphedema and venous diseases | |
| sensushealthcare.com | 2010 | Boca Raton, United States | $12.24M | 42 | Non-invasive skin cancer treatments are developed and marketed. | |
| theragenics.com | 1981 | Buford, United States | $9.44M | 566 | Manufacturer of surgical products and brachytherapy devices |
Detailed competitors of Concure Oncology
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Oncology
3 companies that operate in the same segment as Concure Oncology (Oncology) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Concure Oncology
Concure Oncology was founded in 2014 and raised its 1st funding round 1 year after it was founded.
Concure Oncology is headquartered in Mercer Island, United States. It is registered at Mercer Island, Washington, United States.
Concure Oncology is a funded company, having raised a total of $14.04M across 6 funding rounds to date. The company's 1st funding round was a Seed of $500K, raised on Dec 2015.
Concure Oncology provides an innovative cancer treatment for women diagnosed with early-stage breast cancer. The company has developed a proprietary technology, Breast Microseed Treatment involves the use of Brancy therapy for the precise placement of radioactive seeds in the breast that slowly release the prescribed dose safely over time. This radiation therapy will help the women with early-stage breast cancer to prevent the recurrence of cancer by treating the surgical site and surrounding tissue after the cancerous tumor is removed.
Concure Oncology's top competitors include Koya Medical, Sensus Healthcare and Theragenics.
Concure Oncology has 1 investor. Key investors include Cascadia Venture Forum.